https://edition.cnn.com/2020/04/22/health/coronavirus-ventilator-patients-die/index.html
Interesting as I read this study to show a 75% rate of survival of patients on ventilators closely aligned to the mesoblast 12.
the numbers seem to be moving around a bit. There will be two things to keep a close eye on - more broad data on survival rates of ventilated patients and the mesoblast trial results.
this shows the importance of the trial and control to determine the effectiveness. Signs are very encouraging but there seems to be a lot of talk around certainty of success on a sample of 12 when compared to the survival rates from two New York hospitals when the numbers in New York State alone seem to be moving around.
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-708
-
- There are more pages in this discussion • 140 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.005(0.47%) |
Mkt cap ! $1.216B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.10 | $1.06 | $3.371M | 3.135M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 45345 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 3875 | 2 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |